Revised forecast
Fiscal year ending March 2027 · Full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
Regarding the global economy in the next fiscal year, the company described risks to energy supplies and international logistics arising from instability in the Middle East, as well as uncertainty and downside risks stemming from factors including U.S. trade policy. No specific explanation was provided as the reason for revising the forecast figures.
Impairment loss of ¥21,913 million. The explanation of operating profit states that impairment losses and other items were recognized on investments in an equity-method affiliate engaged in the phenol business in China, but does not disclose the individual amount of that loss.
| Item | Details |
|---|---|
| Net Sales | Not disclosed → ¥1,900,000 million（+13.9%） |
| Operating profit | Not disclosed → ¥83,000 million（+12.5%） |
| Profit attributable to owners of the parent | Not disclosed → ¥45,000 million（+30.9%） |
| Net income per share | Not disclosed → 124.48 yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Previous-period results | Fiscal year ended March 2026: revenue of ¥1,668,754 million, operating profit of ¥73,809 million, profit attributable to owners of the parent of ¥34,378 million, and basic earnings per share of ¥91.62 |
| Reason for the revision | Regarding the global economy in the next fiscal year, the company described risks to energy supplies and international logistics arising from instability in the Middle East, as well as uncertainty and downside risks stemming from factors including U.S. trade policy. No specific explanation was provided as the reason for revising the forecast figures. |
| Details and amount of extraordinary loss | Impairment loss of ¥21,913 million. The explanation of operating profit states that impairment losses and other items were recognized on investments in an equity-method affiliate engaged in the phenol business in China, but does not disclose the individual amount of that loss. |
| Dividend forecast revision | For the fiscal year ending March 2027, the company plans to pay an interim dividend of ¥37.50, a year-end dividend of ¥37.50 and an annual dividend of ¥75. No indication is provided as to whether this constitutes a revision. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue for the fiscal year ended March 2026 decreased due to lower selling prices resulting from declines in the prices of raw materials such as naphtha, as well as lower sales, mainly in the Basic & Green Materials segment. Core operating profit decreased due to factors including a deterioration in inventory valuation gains and losses, while operating profit was also affected by the recognition of impairment losses and other items on investments in equity-method affiliates engaged in the phenol business in China. For the fiscal year ending March 2027, the company cited risks related to the situation in the Middle East, energy supplies, international logistics and U.S. trade policy, but did not provide a detailed explanation of the specific factors behind the projected increase in profit.